Maternal Vaccination Not Tied to Infant Hospitalization, Death

Share this content:
Maternal Vaccination Not Tied to Infant Hospitalization, Death
Maternal Vaccination Not Tied to Infant Hospitalization, Death

TUESDAY, Feb. 20, 2018 (HealthDay News) -- Maternal receipt of influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines is not associated with infant hospitalization or death in the first six months of life, according to a study published online Feb. 20 in Pediatrics.

Lakshmi Sukumaran, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the correlation between maternal receipt of influenza and Tdap vaccines and the risk of infant hospitalization or death. Singleton, live-birth pregnancies in the Vaccine Safety Datalink between 2004 and 2014 were included.

The researchers identified 413,034 live births in the population. In the first six months of life, 25,222 infants had hospitalizations and 157 infants died. There was no correlation between infant hospitalization and maternal influenza (adjusted odds ratio, 1; 95 percent confidence interval, 0.96 to 1.04) or Tdap (adjusted odds ratio, 0.94; 95 percent confidence interval, 0.88 to 1.01) vaccinations. No correlation was identified between infant mortality and maternal influenza (adjusted odds ratio, 0.96; 95 percent confidence interval, 0.54 to 1.69) or Tdap (adjusted odds ratio, 0.44; 95 percent confidence interval, 0.17 to 1.13) vaccinations.

"These findings support the safety of current recommendations for influenza and Tdap vaccination during pregnancy," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »